Cargando…
Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin
SIMPLE SUMMARY: The tumor suppressor p53 is frequently mutated in human cancer. Accumulation of missense mutant p53 (mutp53) in tumors is crucial for malignant progression, and cancers are often addicted to oncogenic mutp53. However, strategies to deplete mutp53 have not yet been established. Recent...
Autores principales: | Alalem, Mohamed, Bhosale, Mrinalini, Ranjan, Atul, Yamamoto, Satomi, Kaida, Atsushi, Nishikawa, Shigeto, Parrales, Alejandro, Farooki, Sana, Anant, Shrikant, Padhye, Subhash, Iwakuma, Tomoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454493/ https://www.ncbi.nlm.nih.gov/pubmed/36077724 http://dx.doi.org/10.3390/cancers14174187 |
Ejemplares similares
-
DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen
por: Nishikawa, Shigeto, et al.
Publicado: (2022) -
Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015) -
p53 as a Regulator of Lipid Metabolism in Cancer
por: Parrales, Alejandro, et al.
Publicado: (2016) -
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
por: Nishikawa, Shigeto, et al.
Publicado: (2023) -
Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members
por: Kaida, Atsushi, et al.
Publicado: (2021)